The stock of Lyell Immunopharma Inc (NASDAQ:LYEL) last traded at $1.38, up 5.75% from the previous session.
LYEL stock price is now -43.16% away from the 50-day moving average and -33.55% away from the 200-day moving average. The market capitalization of the company currently stands at $351.82M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $6 to $1, H.C. Wainwright Downgraded its rating from Buy to Neutral for Lyell Immunopharma Inc (NASDAQ: LYEL). On August 28, 2023, JP Morgan Downgraded its previous ‘Overweight’ rating to ‘Neutral’ on the stock reducing its target price from $15 to quote $5, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, Klausner Richard, Director sold 58,020 shares of the company’s stock on Aug 15 ’23. The stock was sold for $132,286 at an average price of $2.28. Upon completion of the transaction, the Director now directly owns 930,880 shares in the company, valued at $1.28 million. A total of 53.44% of the company’s stock is owned by insiders.
During the past 12 months, Lyell Immunopharma Inc has had a low of $1.25 and a high of $3.41. As of last week, the company has a debt-to-equity ratio of 0.10, a current ratio of 16.51, and a quick ratio of 16.51. The fifty day moving average price for LYEL is $2.4073 and a two-hundred day moving average price translates $2.07365 for the stock.
The latest earnings results from Lyell Immunopharma Inc (NASDAQ: LYEL) was released for 2024-03-31. The net profit margin was -335794.12% and return on equity was -32.93% for LYEL. The company reported revenue of $3000.0 for the quarter, compared to $65000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -95.38 percent.
